Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04938869 · ClinicalTrials.gov registry record · NA
Continuous Glucose Monitor Application After Hospital Discharge for the Improvement of Outcomes in Patients With Poorly Controlled Type 2 Diabetes and Active Cancer
A NA study, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT04938869 is a NA study that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 3 participants.
The verdict
NCT04938869, a NA study, has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
This clinical trial studies the effect of a continuous glucose monitor application in improving outcomes in patients with poorly controlled type 2 diabetes and active cancer. Patient satisfaction with type 2 diabetes management influences medication-taking behavior as well as health outcomes. Adding continuous glucose monitor application to diabetes treatment plan after hospital discharge plan may improve patient satisfaction and reduce diabetes distress.
Interventions
- OTHER Survey Administration
- OTHER Medical Device Usage and Evaluation
- OTHER Educational Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2021-10-05 |
| Est. Completion | 2022-02-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04938869
The ClinicalTrials.gov registry entry for NCT04938869 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Survey Administration is the first listed.
NCT04938869 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04938869 about?
NCT04938869 is a clinical study titled "Continuous Glucose Monitor Application After Hospital Discharge for the Improvement of Outcomes in Patients With Poorly Controlled Type 2 Diabetes and Active Cancer". This clinical trial studies the effect of a continuous glucose monitor application in improving outcomes in patients with poorly controlled type 2 diabetes and active cancer. Patient satisfaction with type 2 diabetes management influences medication-taking behavior as well as health outcomes. Adding...
What is the current status of trial NCT04938869?
This trial is currently completed. It is a NA study. The enrollment target is 3 participants. The study started on 2021-10-05. Estimated completion is 2022-02-17.
What interventions are being tested in trial NCT04938869?
The interventions under investigation include: Survey Administration (OTHER), Medical Device Usage and Evaluation (OTHER), Educational Intervention (OTHER).
Who is sponsoring clinical trial NCT04938869?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.